EQ Earnings — Equillium, Inc. Common Stock Post-ER Performance | BigEarnings
EQ — Equillium, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$2.90
Market Cap$183.4M
P/E—
52W Range$0.27 – $3.10
Next Earnings2026-08-13
About Equillium, Inc. Common Stock
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
